Categories Consumer, U.S. Markets News

Tilray is on a consolidation spree

On the heels of a string of partnership deals, Tilray (TLRY) on Tuesday announced that it was acquiring Canada-based Natura Naturals Holdings Inc, a licensed cultivator of cannabis.

The deal gives Tilray Natura’s 662,000 square-foot greenhouse cultivation facility. Under the deal, Tilray would pay Natura CAD 15 million in cash and CAD 20 million in Tilray Class 2 common stock.

If Natura achieves certain milestones over the next year, the company would be entitled to up to another CAD 35 million of Tilray stock, lifting the total deal value to CAD 70 million.

tilray, canopy stocks
Photo by Sharon McCutcheon on Unsplash (Image for representation)

The transaction is expected to be completed in a month’s time. TLRY shares fell over 5% on Tuesday.

Tilray has been on a consolidation spree lately and the deal with Natura marks the fourth in less than 40 days. Last week, the company had inked a $100-million partnership with brand management company Authentic Brands Group.

Under the long-term revenue-sharing agreement, both the parties would together develop and distribute weed-based consumer products in regions where regulators have shown a green flag. The products are likely to hit Canada and the US by next year.

Budweiser-parent mulls pot-based drinks, inks JV with Tilray

This agreement comes barely a month after AB InBev (BUD), the maker of Budweiser beer, inked a $100-million deal with Tilray to study the production and distribution of non-alcoholic drinks infused with cannabis components. The joint venture, in its initial phase, is focused only in Canada.

A couple of days before the deal with AB InBev, Tilray sealed another agreement with German company Sandoz, a subsidiary of Novartis (NVS). Under this agreement, the two companies would collaborate to make new medical marijuana products and co-brand some non-combustible products.

 

Follow our Google News edition to get the latest stock market, earnings, and financial news at your fingertips 

Most Popular

BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to

Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights

Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per

BA Earnings: Highlights of Boeing’s Q1 2024 financial results

The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top